News
1d
The Punch on MSNSickle cell disease and knee joint pain: Why steriods aren’t always the best optionFor people living with sickle cell disease, joint pain, especially in the knees, can be a frustrating and persistent ...
Individuals with both sickle cell disease (SCD) and sickle cell trait are at higher risk than others of developing renal medullary cancer (RMC), the rarest and deadliest subtype of kidney cancer.
Sickle cell disease (SCD) altered CD8+ T-cell chromatin architecture, triggering ferroptosis and weakening antitumor immunity ...
Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.
Race has no biological basis and no effect on the onset or progression of disease.
11h
The Punch on MSNWould you love to donate your organs after death?Organ transplantation represents one of the most remarkable achievements of modern medicine. Yet, in countries like Nigeria, ...
The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.
The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an ...
For the first time in his life, a young New Jersey man is pain-free thanks to a new gene treatment working to cure patients ...
3d
News Medical on MSNMUSC creates protocol to improve emergency care for pediatric sickle cell patientsThe Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at the Medical University of South Carolina ...
Sickle cell disease (SCD) affects an estimated 20 million people worldwide. As a genetic condition that leads to severe, lifelong complications, SCD remains a significant unmet medical need with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results